Anti-DNA antibodies cross-reactive with β₂-glycoprotein I induce monocyte tissue factor through the TLR9 pathway

References

• Svenungsson E, Antovic A. The antiphospholipid syndrome – often overlooked cause of vascular occlusions? J Intern Med. 2020;287(4):349–372.
   Web of Science ®Google Scholar
• Linnemann B. Antiphospholipid syndrome – an update. VASA. 2018;47(6):451–464.
   Web of Science ®Google Scholar
• Cervera R, Piette J-C, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46(4):1019–1027.
   PubMed Web of Science ®Google Scholar
• de Laat HB, Derksen R, Urbanus RT, et al. beta2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome. Blood. 2004;104(12):3598–3602.
   Web of Science ®Google Scholar
• Chaturvedi S, McCrae KR. Diagnosis and management of the antiphospholipid syndrome. Blood Rev. 2017;31(6):406–417.
   PubMed Web of Science ®Google Scholar
• de Laat B, Derksen R, Urbanus RT, et al. IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood. 2005;105(4):1540–1545.
   PubMed Web of Science ®Google Scholar
• Agar Ç, van Os GMA, Mörgelin M, et al. Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome. Blood. 2010;116(8):1336–1343.
   PubMed Web of Science ®Google Scholar
• Mahler M, Norman GL, Meroni PL, et al. Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome. Autoimmun Rev. 2012;12(2):313–317.
   Web of Science ®Google Scholar
• Cocca BA, Seal SN, D'Agnillo P, et al. Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells. Proc Natl Acad Sci USA. 2001;98(24):13826–13831.
   Web of Science ®Google Scholar
• Sorice M, Longo A, Capozzi A, et al. Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts. Arthritis Rheum. 2007;56(8):2687–2697.
   PubMedGoogle Scholar
• Zhou H, Yan Y, Xu G, et al. Toll-like receptor (TLR)-4 mediates anti-β2GPI/β2GPI-induced tissue factor expression in THP-1 cells. Clin Exp Immunol. 2011;163(2):189–198.
   Web of Science ®Google Scholar
• Meroni PL, Borghi MO, Raschi E, et al. Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol. 2011;7(6):330–339.
   PubMed Web of Science ®Google Scholar
• Prinz N, Clemens N, Strand D, et al. Antiphospholipid antibodies induce translocation of TLR7 and TLR8 to the endosome in human monocytes and plasmacytoid dendritic cells. Blood. 2011;118(8):2322–2332.
   PubMed Web of Science ®Google Scholar
• Brandt KJ, Fickentscher C, Boehlen F, et al. NF-κB is activated from endosomal compartments in antiphospholipid antibodies-treated human monocytes. J Thromb Haemost. 2014;12(5):779–791.
   Web of Science ®Google Scholar
• Nishimura M, Nii T, Trimova G, et al. The NF-kB specific inhibitor DHMEQ prevents thrombus formation in a mouse model of antiphospholipid syndrome. J Nephropathol. 2013;2(2):114–121.
   Google Scholar
• Virachith S, Saito M, Watanabe Y, et al. Anti-β2 -glycoprotein I antibody with DNA binding activity enters living monocytes via cell surface DNA and induces tissue factor expression. Clin Exp Immunol. 2019;195(2):167–178.
   Web of Science ®Google Scholar
• Aringer M, Costenbader K, Daikh D, et al. 2019 European League against rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151–1159.
   PubMed Web of Science ®Google Scholar
• Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.
   PubMed Web of Science ®Google Scholar
• Kubota T, Watanabe N, Kanai Y, et al. Enhancement of oxidative cleavage of DNA by the binding sites of two anti-double-stranded DNA antibodies. J Biol Chem. 1996;271(11):6555–6561.
   Web of Science ®Google Scholar
• Stollar BD, Zon G, Pastor RW. A recognition site on synthetic helical oligonucleotides for monoclonal anti-native DNA autoantibody. Proc Natl Acad Sci Usa. 1986;83(12):4469–4473.
   Web of Science ®Google Scholar
• Fenton KA, Tømmerås B, Marion TN, et al. Pure anti-dsDNA mAbs need chromatin structures to promote glomerular mesangial deposits in BALB/c mice. Autoimmunity. 2010;43(2):179–188.
   Web of Science ®Google Scholar
• Lenert PS. Classification, mechanisms of action, and therapeutic applications of inhibitory oligonucleotides for Toll-like receptors (TLR) 7 and 9. Mediators Inflamm. 2010;2010:986596.
   PubMed Web of Science ®Google Scholar
• Torigoe M, Sakata K, Ishii A, et al. Hydroxychloroquine efficiently suppresses inflammatory responses of human class-switched memory B cells via Toll-like receptor 9 inhibition. Clin Immunol. 2018;195:1–7.
   PubMed Web of Science ®Google Scholar
• Zhu Y-Z, Xu Q-Q, Wu D-G, et al. Japanese encephalitis virus enters rat neuroblastoma cells via a pH-dependent, dynamin and caveola-mediated endocytosis pathway. J Virol. 2012;86(24):13407–13422.
   PubMed Web of Science ®Google Scholar
• Rand JH, Wu X-X, Quinn AS, et al. Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers. Blood. 2008;112(5):1687–1695.
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y, Rauch J, Massicotte H, et al. Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. N Engl J Med. 1983;308(8):414–420.
   Web of Science ®Google Scholar
• Radic MZ, Weigert M. Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol. 1994;12:487–520.
   PubMed Web of Science ®Google Scholar
• Stemmer C, Richalet-Sécordel P, van Bruggen M, et al. Dual reactivity of several monoclonal anti-nucleosome autoantibodies for double-stranded DNA and a short segment of histone H3. J Biol Chem. 1996;271(35):21257–21261.
   Web of Science ®Google Scholar
• Kumar S, Nagl S, Kalsi JK, et al. Anti-cardiolipin/beta-2 glycoprotein activities co-exist on human anti-DNA antibody light chains. Mol Immunol. 2003;40(8):517–530.530.
   Web of Science ®Google Scholar
• Inoue K, Ishizawa M, Kubota T. Monoclonal anti-dsDNA antibody 2C10 escorts DNA to intracellular DNA sensors in normal mononuclear cells and stimulates secretion of multiple cytokines implicated in lupus pathogenesis. Clin Exp Immunol. 2020;199(2):150–162.
   Web of Science ®Google Scholar
• Lu Q, Kanai Y, Kubota T. The emergence of anti-dsDNA antibodies precedes nucleosome-specific antibodies in MRL/lpr and MRL/+ mice. J Med Dent Sci. 2003;50(1):9–15.
   Google Scholar
• Ermakov KV, Bukhvostov AA, Vedenkin AS, et al. The unique single-stranded cfDNA species in retinoblastoma patients blood plasma: beyond new HPLC technology. Biomark J. 2019;5(3):1–4.
   Google Scholar
• Burnham P, Kim MS, Agbor-Enoh S, et al. Single-stranded DNA library preparation uncovers the origin and diversity of ultrashort cell-free DNA in plasma. Sci Rep. 2016;6:27859.
   PubMed Web of Science ®Google Scholar
• El Kebir D, Damlaj A, Makhezer N, et al. Toll-like receptor 9 signaling regulates tissue factor and tissue factor pathway inhibitor expression in human endothelial cells and coagulation in mice. Crit Care Med. 2015;43(6):e179–e189.
   Web of Science ®Google Scholar
• Mustelin T, Lood C, Giltiay NV. Sources of pathogenic nucleic acids in systemic lupus erythematosus. Front Immunol. 2019;10:1028.
   PubMed Web of Science ®Google Scholar
• Monzavi SM, Alirezaei A, Shariati-Sarabi Z, et al. Efficacy analysis of hydroxychloroquine therapy in systemic lupus erythematosus: a study on disease activity and immunological biomarkers. Inflammopharmacol. 2018;26(5):1175–1182.
   PubMed Web of Science ®Google Scholar
• Schreiber K, Breen K, Parmar K, et al. The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies. Rheumatology (Oxford)). 2018;57(1):120–124.
   PubMed Web of Science ®Google Scholar